Search clinical trials for: Octreotide long-acting release (LAR)

Total 5053 results

Novartis Pharmaceuticals

Completed

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

Dumping Syndrome

Belgium, Netherlands, Germany, France, United States
Federico II University

Completed

Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly (GLUSSA)

Acromegaly

Italy
Mayo Clinic
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Recruiting

Neuromuscular Intervention Targeted to Mechanisms of ACL Load in Female Athletes

Rehabilitation | ACL Reconstruction

United States
Columbia University

Terminated

Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors (PASSILCORT)

Pituitary Tumor | ACTH-producing Pituitary Tumour

United States
Federico II University
Ospedali dei Colli

Completed

GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma (SS-HCC)

Advanced Hepatocellular Carcinoma

Italy
Tokat Gaziosmanpasa University

Completed

SUN LIGHT EXPOSURE AND VITAMIN D LEVEL IN NURSING HOME

Vitamin D Deficiency | Nursing Home

Turkey
National Institute of Diabetes and Digestive and...

Completed

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

Acromegaly | Pituitary Neoplasm

United States
Federico II University

Completed

Cardiovascular Outcome After Surgery or Somatostatin Analogues (CVAcro)

Acromegaly

Italy
Grupo Espanol de Tumores Neuroendocrinos

Completed

Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET (EVERLAR)

Gastrointestinal Neoplasms

Spain
Institut du Cancer de Montpellier - Val d'Aurelle
Intuitive Surgical

Active, not recruiting

Rectal Surgery Evaluation Trial (RESET) (RESET)

Rectal Cancer

France
Medtronic - MITG
University of South Florida; Duke University; Providence Medical Research Center

Terminated

Radial Reload Open LAR Case Series

Rectal Cancer | Low Anterior Resection | Proctosigmoid Resection

United States
Odense University Hospital
Vejle Hospital

Unknown

Peritoneal Microdialysis in Patients Undergoing Low Anterior Resection for Rectum Cancer

Cancer

Denmark
University of Basel
Senevita AG

Completed

Improving Pain Management in Nursing Homes: a Pilot Study (ProQuaS)

Pain Management

Switzerland
University of Pittsburgh
RAND

Completed

Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes

Adverse Drug Events

United States
McMaster University

Unknown

Assessment of SOLO Vibrating Mesh Nebulizer for Allergen-Induced Late Asthmatic Responses (SOLO-LAR)

Asthma

Canada
Radboud University Medical Center
Novartis

Completed

Everolimus and LongActing Octreotide Trial in Polycystic Livers (ELATE)

Polycystic Liver Disease

Netherlands
Gérond'if

Completed

Tolerance for Using Virtual Reality With Subjects Living in Accommodation Establishment for the Elderly Dependent (EHPAD) (RAVI)

Anxiety Disorders | Residents of Retirement Home (EHPAD)

France
Federico II University

Completed

Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly (HDacro)

Acromegaly

Italy
Medtronic - MITG
Duke University; University Hospitals Cleveland Medical Center

Terminated

Radial Reload Laparoscopic LAR Case Series

Colorectal Cancer

United States
Novartis Pharmaceuticals

Completed

Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs (COOPERATE-1)

Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System

Germany
Advanced Accelerator Applications

Completed

A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours (NETTER-1)

Carcinoid Tumor of the Small Bowel | Neuroendocrine Tumour

United States, United Kingdom, Italy, Belgium, France, Germany, Portugal, Spain
Southwest Hospital, China

Recruiting

PR in Endoscopic LAR for Rectal Cancer

Rectal Carcinoma

China
Azienda Ospedaliero-Universitaria di Parma

Active, not recruiting

Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients (DRINN)

Cognitive Deficit | Dysglycemia

Italy
First Affiliated Hospital of Zhejiang University

Unknown

Defunctioning Cannula Ileostomy After Lower Anterior Resection of Rectal Cancer

Rectal Neoplasms

China
Sinotau Pharmaceutical Group

Recruiting

A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs

Neuroendocrine Tumors

China
Novartis Pharmaceuticals

Completed

Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma. (Passion I)

Non-functioning Pituitary Adenoma

Brazil
Hospital Universitari de Bellvitge

Recruiting

Home Monitoring Vs. Hospitalization for Mild Acute Pancreatitis (RHINO)

Acute Pancreatitis

Spain
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly

Acromegaly
University of North Carolina, Chapel Hill

Completed

Daily Mouth Care to Prevent Pneumonia in Nursing Homes

Pneumonia | Aging | Nursing Home
Erasmus Medical Center
Novartis

Unknown

Pasireotide LAR and Pegvisomant Study in Acromegaly (PAPE)

Acromegaly

Netherlands
Johann Wolfgang Goethe University Hospital

Completed

Safety of Bronchial Allergen Challenge and Predictors for Positive Reaction.

House Dust Mite Allergy | Bronchial Hyperresponsiveness

Germany
Associazione Ginco Ticino

Completed

San Rocco Study: Implementation of the Non-pharmacological Therapies for People With Dementia Living in Nursing Home

Dementia | Nursing Home | Staff

Switzerland
Mario Negri Institute for Pharmacological Research

Completed

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (ALADIN2)

Autosomal Dominant Polycystic Kidney Disease

Italy
Camurus AB
Novartis

Completed

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Neuroendocrine Tumors | Acromegaly

Germany, Sweden, France, Italy
Federico II University

Completed

Prediction of Tumor Shrinkage in Acromegaly

Acromegaly

Italy
Memorial Sloan Kettering Cancer Center

Completed

A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

Neuroendocrine Tumors

United States
Novartis Pharmaceuticals
Quintiles, Inc.

Completed

STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea

Neoplasms | Diarrhea

United States
Radboud University Medical Center
University Medical Center Groningen; Catharina Ziekenhuis Eindhoven; St. Antonius... and other collaborators

Completed

Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias (OCEAN)

Anemia | Vascular Malformations | Gastrointestinal Hemorrhage | Angiodysplasia

Netherlands
Mayo Clinic

Completed

Pasireotide LAR in Severe Polycystic Liver Disease (SOM230)

Autosomal Dominant Polycystic Kidney Disease | Polycystic Liver Disease | Autosomal Dominant Polycystic Liver Disease | Somatostatin Analogs

United States
Carmen Schade-Brittinger

Completed

Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut

Neuroendocrine Tumors

Germany
Assistance Publique Hopitaux De Marseille

Completed

Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas (CEVOREM)

Recurrent Meningiomas | Resistant Meningiomas

France
Ipsen

Completed

Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR

Acromegaly

Australia
Northeastern University
Vigorous Mind, Inc.

Completed

Robot for Alleviating Loneliness and Engaging Nursing Home Residents

Nursing Home Resident

United States
Novartis

Terminated

Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.

Proliferative Diabetic Retinopathy

Switzerland
AstraZeneca

Completed

Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)

Type 2 Diabetes Mellitus

Canada, United States
Novartis Pharmaceuticals

Completed

Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)

Neuroendocrine Tumors

United States
Virginia Commonwealth University
Novartis; Thoratec Corporation

Completed

Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)

Gastrointestinal Bleeding

United States
Cliniques universitaires Saint-Luc- Université...

Terminated

Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation (SCIROCCO)

Neuroendocrine Tumors | Carcinoid Syndrome
Novartis Pharmaceuticals

Completed

Pediatric Hypothalamic Obesity

Obesity

United States
University of British Columbia

Terminated

Prader-Willi Syndrome and Appetite

Hyperphagia | Prader-Willi Syndrome

Canada

Search clinical trials for: Octreotide long-acting release (LAR)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations